To Evaluate the Safety, Tolerability, and Preliminary Efficacy of XH001 Injection as Adjuvant Therapy in Patients With High-risk Recurrent Solid Tumors

Clinical trial NCT07594964 · RECRUITING

Trial details

NCT number: NCT07594964
Sponsor: Shenzhen Xinhe Biomedical
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Biliary Cancer (Cholangiocarcinoma, Gall Bladder Cancer)Pancreatic Ductal Adenocarcinoma (PDAC)Hepatocellular Carcinoma (HCC)Gastric Cancer (GC)

Start date: 2025-08-25
Primary completion: 2029-10-30
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.